GVT
BSX icon

Genesee Valley Trust’s Boston Scientific BSX Stock Holding History

Genesee Valley Trust’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14,153
Closed -$251K – 280
2015
Q1 		$251K Sell
14,153
-8,521
-38% -$135K 0.16% 215
2014
Q4 		$300K Buy
+22,674
New +$290K 0.19% 159
2014
Q1 		– Sell
-16,225
Closed -$195K – 307
2013
Q4 		$195K Sell
16,225
-83
-0.5% -$981 0.13% 281
2013
Q3 		$191K Sell
16,308
-5,014
-24% -$54.2K 0.14% 265
2013
Q2 		$198K Buy
+21,322
New +$181K 0.16% 257

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Genesee Valley Trust's BSX Position: Q2 2015 in Review

Genesee Valley Trust sold out of Boston Scientific (BSX) in Q2 2015, closing a stake of 14,153 shares — an estimated $251K sold.

Genesee Valley Trust first reported a position in BSX in Q2 2013 and held it in 5 quarters. The position peaked at $300K in Q4 2014. 471 funds tracked by Wall St. Rank hold BSX as of Q2 2015.

  • Genesee Valley Trust reported no remaining Boston Scientific position as of Q2 2015 after selling out during the quarter.
  • Genesee Valley Trust sold 14,153 Boston Scientific shares in Q2 2015, an estimated $251K.
  • Genesee Valley Trust first reported a position in Boston Scientific in Q2 2013 and held it in 5 quarters.
  • Genesee Valley Trust's Boston Scientific position peaked at $300K in Q4 2014.
  • 471 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2015.

Based on Genesee Valley Trust's 13F filing for Q2 2015, filed 10 Aug 2015.